Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42